Medingo Ltd. develops cutting edge technologies for the welfare of people living with diabetes. The company’s flagship product, the Solo™ Insulin Patch Pump System, is the result of intensive customer research and cutting-edge development that resulted in a multitude of significant patents. We believe that Solo will be of interest not only to people who already use insulin pumps, but also to people who have chosen not to pump for various reasons.

Company was acquired by Roche